Abstract:(-)-Epigallocatechin gallate (EGCG), the most abundant tea catechin, has been proposed to be beneficial to human health based on its strong antioxidative and other biological activities in vitro. Inadequate knowledge regarding the bioavailability and biotransformation of EGCG in humans, however, has limited our understanding of its possible beneficial health effects. In this study, 4',4' '-di-O-methyl-EGCG (4',4' '-DiMeEGCG) was detected in human plasma and urine by LC/MS/MS following green tea ingestion. Both 4',4' '-DiMeEGCG and EGCG reached peak plasma values (20.5 +/- 7.7 and 145.4 +/- 31.6 nM, respectively, in 4 subjects) at 2 h after the dose. The half-lives of 4',4' '-DiMeEGCG and EGCG were 4.1 +/- 0.8 and 2.7 +/- 0.9 h, respectively. The cumulative urinary excretion of 4',4' '-DiMeEGCG during a 24 h period was 140.3 +/- 48.6 microg, about 5-fold higher than that of EGCG, but the excreted 4',4' '-DiMeEGCG and EGCG in urine only accounted for about 0.1% of ingested EGCG. (-)-5-(3',4',5'-Trihydroxyphenyl)-gamma-valerolactone (M4) and (-)-5-(3',4'-dihydroxyphenyl)-gamma-valerolactone (M6), along with another possible ring-fission metabolite, (-)-5-(3',5'-dihydroxyphenyl)-gamma-valerolactone (M6'), were detected in human urine after green tea ingestion. The cumulative excretion of M4, M6', and M6 during a 24 h period ranged from 75 microg to 1.2 mg, 0.6 to 6 mg, and 0.6 to 10 mg, respectively. The combined excretion of all three ring-fission metabolites accounted for 1.5-16% of ingested catechins. M4, M6', and M6 were all observed after the ingestion of pure EGCG or EGC by human subjects, whereas only M6 was produced after EC ingestion. These metabolites as well as monomethylated EGCG were detected in mice and rats after tea or EGCG administration, and the tissue levels reflected the rather low bioavailability of EGCG in rats. The presently characterized methylated EGCG metabolites and ring-fission products exist in substantial quantities and may contribute to the biological activities of tea.

Formation And Identification Of 4 '-O-Methyl-(-)-Epigallocatechin In Humans

Identification and Characterization of Methylated and Ring-Fission Metabolites of Tea Catechins Formed in Humans, Mice, and Rats.

Structural Identification Of Two Metabolites Of Catechins And Their Kinetics In Human Urine And Blood After Tea Ingestion

Glucuronides Of Tea Catechins: Enzymology Of Biosynthesis And Biological Activities

Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry.

Metabolic fate of tea polyphenols in humans.

Enzymology Of Methylation Of Tea Catechins And Inhibition Of Catechol-O-Methyltransferase By (-)-Epigallocatechin Gallate

Stability, Cellular Uptake, Biotransformation, And Efflux Of Tea Polyphenol (-)-Epigallocatechin-3-Gallate In Ht-29 Human Colon Adenocarcinoma Cells

Bioavailability and biological activity of tea polyphenols

Characterization Of Pu-Erh Tea Using Chemical And Metabolic Profiling Approaches

Catechin-enriched Green Tea Extract As a Safe and Effective Agent for Antimicrobial and Anti-Inflammatory Treatment

DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES

Effects Of Catechin Enriched Green Tea On Body Composition

Synthesis And Biological Testing Of Novel Glucosylated Epigallocatechin Gallate (Egcg) Derivatives

Metabolism of Green Tea Catechins: An Overview

Reciprocal Interactions between Epigallocatechin-3-gallate (EGCG) and Human Gut Microbiota In Vitro

Characterization of two O-methyltransferases involved in the biosynthesis of O-methylated catechins in tea plant

Bulk Preparation of (−)-Epigallocatechin Gallate-Rich Extract from Green Tea

Identification of Epigallocatechin-3-Gallate (EGCG) from Green Tea Using Mass Spectrometry

Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives

Pharmacokinetics and Biotransformation of Tea Polyphenols